Travere Therapeutics

Travere discovers and develops drugs for the treatment of debilitating and often life-threatening catastrophic diseases. Travere Therapeutics is advancing therapeutic candidates for rare diseases in the fields of nephrology, hepatology, and metabolism; sponsoring free genetic testing aimed at improving the diagnostic process for children with cholestatic diseases; collaborating with patient advocacy organizations to meet the diverse needs of patients and their families; and ensuring broad access to and education about its FDA-approved therapies.